期刊文献+

慢性肾脏病患者接种乙肝疫苗疗效研究 被引量:3

Chronic Kidney Diseaes Hepatitis B Vaccine Efficacy
在线阅读 下载PDF
导出
摘要 目的:探讨慢性肾脏病(chronic kidney disease,CKD)早中期(CKD1~3期)、晚期(CKD4~5期)患者接种乙肝疫苗后的反应情况,明确CKD患者接种乙肝疫苗的最佳时期,使CKD患者产生主动免疫抵御HBV感染。方法:对乙肝两对半全阴性的慢性肾脏病早中期、晚期患者接种乙肝疫苗,观察两组患者乙肝表面抗体的阳转率及抗体滴度高低情况,同时,将CKD早中期组分为接受或未接受激素/免疫抑制剂两组,所有CKD患者再分为男性、女性两组,分别对上述分组进行比较,观察各组患者乙肝表面抗体的阳转率及抗体滴度高低情况。结果:(1)CKD早中期患者接种乙肝疫苗后,乙肝表面抗体阳转率明显高于CKD晚期患者,且抗体滴度明显高于CKD晚期组。(2)在CKD早中期组中接受或未接受激素/免疫抑制剂治疗的患者中抗体阳转率差异无统计学意义,但接受激素/免疫抑制剂组抗体滴度更高。(3)性别不是影响乙肝疫苗接种效果的因素。结论:CKD早中期患者接种乙肝疫苗疗效优于CKD晚期患者,激素及免疫抑制剂治疗不影响CKD早中期患者接种乙肝疫苗的疗效,性别不影响接种效果。 Objective: To compare the response rate to HB vaccine in CKD stage 1 ~ 3 patients with that in CKD stage 4 ~ 5and clear the best period of hepatitis B vaccination for patients with CKD,which help to produce active immunization against hepatitis B virus infection for patients with CKD. Methods: Patients with group CKD( 1 ~ 3),and group CKD( 4 ~ 5) were all vaccinated against hepatitis B virus infection. Then the antibody of hepatitis B was detected. At the same time,CKD( 1 ~ 3) patients were divided into two groups: Group- A: to accept hormone / immunosuppressants,Group- B: not to accept. All participants with CKD were divided into two groups: male and female. After completion of the vaccination schedule,seroconversion and seroprotection rates in each group were investigated. Results:( 1) The seroconversion rate of patients with CKD( 1 ~ 3) was significantly higher than that of patients with CKD( 4 ~ 5),and the degree of HBV- Ab was significantly higher than that of patients with CKD( 4 ~ 5).( 2) There was no difference of the positive rate of HBV- Ab and the degree of HBV- Ab between the two groups who accepted or didn't accept hormone / immunosuppressants.( 3) There was no significant difference of the effect of hepatitis B vaccination between males and females. Conclusion: CKD( 1 ~ 3) patients showed higher response rate than patients with CKD( 4 ~ 5). Hormone and immunosuppressants treatment did not affect the effect of hepatitis B vaccination of patients with CKD 1 ~ 3,and gender was not associated with seroconversion.
出处 《中国中西医结合肾病杂志》 2015年第5期418-421,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
基金 国家自然科学基金资助项目(No.81170634) 福建医科大学附属龙岩市第一医院优秀青年医师科研项目(No.0010)
关键词 慢性肾脏病 乙肝疫苗 抗体阳转率 Chronic kidney disease Hepatitis B vaccine Seroconversion
  • 相关文献

参考文献12

  • 1邵国建,王朝晖,陈晓农,朱萍,陈楠.维持性血透患者乙、丙型肝炎病毒和人免疫缺陷病毒感染随访研究[J].中国中西医结合肾病杂志,2012,13(5):413-416. 被引量:9
  • 2龚震宇,陈恩富,石国祥,梅玲玲,杨介者,黄良,江夏明,王友清,张领凤,尹卡佳,孙韵茹.5μg和10μg基因工程乙肝疫苗加强免疫后效果比较[J].中国公共卫生,2002,18(4):479-480. 被引量:21
  • 3韩田,王明法,王勇.不同剂量重组(酵母)乙肝疫苗接种后抗体阳转率对比[J].职业与健康,2006,22(23):2100-2101. 被引量:5
  • 4http://www, cdc. gov/vaccines/pubs/downloads/dialysis guide -2012. pdf. Guidelines for vaccinating kidney dialysis pa- tients and patients with chronic kidney disease.
  • 5Ghadiani MH, Besharati S, Mousavinasab N, et al. Response rates to HB vaccine in CKD stages 3 ~ 4 and hemodialysis patients. J Res Med Sci,2012,17(6) :527 - 533.
  • 6DaRoza G, Loewen A, Djurdjev O, et al. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better. Am J Kidney Dis,2003,42(6) :1184 - 1192.
  • 7Verkade MA, van Druningen C J, Op de Hoek CT, et al. De- creased antigen- specific T -cell proliferation by moDC among hepatitis B vaccine non- responders on haemodialysis. Clin Exp Med,2007,7( 1 ) :65 -71.
  • 8Caillat- Zucman S, Gimenez J J, Albouze G, et al. HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients. Kidney Int Suppl, 1993,41 :S157- S160.
  • 9Fabrizi F, Dixit V, Martin P, et al. Meta - analysis : the impact of nutritional status on the immune response to hepatitis B virus vaccine in chronic kidney disease. Dig Dis Sci, 2012,57 ( 5 ) : 1366 - 1372.
  • 10胡俊华,王朝晖,沈平雁,张文,任红,李晓,王亚娟,陈楠.肾炎患者糖皮质激素和免疫抑制剂应用中乙肝病毒感染的处理[J].中国中西医结合肾病杂志,2008,9(11):984-987. 被引量:16

二级参考文献35

共引文献59

同被引文献13

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部